drugset / Trial / NCT01397214

Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers

NCT01397214

Phase 1 Completed 103 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

Phase I study of Megace F will be conducted to investigate pharmacokinetics and safety compared to Megace OS. Phase I study divided into 3 parts written as belows. Part 1 Megace F in fasting volunteers vs Megace F in fed volunteers Part 2 Megace F vs Megace OS in fed volunteers Part 3 Megace F vs Megace OS in fasting volunteers

Timeline

Start
2011-07
Primary completion
2011-09
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Megace F Unknown Oral
Comparator Megestrol Acetate Other / unclassified Oral